BELAJAR
PROF.DR.H.GUSBAKTI,MSc,PKK,AIFM
PEMENUHAN DIRI
FULFILLMENT
PELAKSANAAN YANG
PENUH SEMANGAT
PASSIONATE EXECUTION
8TH HABITS
STEVEN R COVEY
MEDS
MOTIVATION
EDUCATION
DEDICATION
SKILL
KENAPA MEMILIH MENJADI
DOKTER
TIPS
TRUST
INTEGRITY
PROACTIVE
SOLUTION
1. PERENCANAAN
BELAJAR
PERENCANAAN
BELAJAR
PERLUKAH?
Teknik Perencanaan
Menyusun Jadwal :
-Menetapkan tujuan
-Waktu produktif
-Kapan kita belajar
-Membuat jadwal
-Rekreasi & kegiatan
di luar belajar
PEMBUATAN JADWAL
FUNGSI
Membantu
penggunaan waktu
seefektif dan seefisien
mungkin
Melatih untuk selalu
siap dg pekerjaan
berikutnya
PERHATIKAN
Setiap mata kuliah
harus tercantum dlm
jadwal
Alokasi waktu bukan
berdasarkan mata
kuliah favorit
Waktu antara
PEMBUATAN JADWAL
Langkah-langkah penyusunan jadwal
Hitung jumlah jam belajar dan waktu yang
tersedia
Isilah waktu-waktu rutin yg diperlukan
Isi waktu-waktu janji (dengan
pembimbing,dll)
Tentukan waktu belajar (sebelum/setelah
kelas?)
Sediakan waktu cadangan/waktu bebas
MEMBACA BUKU
Teknik Membaca Buku
a. Tetapkan tujuan
MENINGKATKAN
KEMAMPUAN MEMBACA
a. Jangan bicara
e. Menggaris bawahi
f.
c. Latihan membaca
cepat/200 kata-menit
Lewis 1986 dapat
ditingkatkan sampai
500kata/menit
d. Teknik
SQ3R,SQ4R,OK4R, dan
PQRST
OK4R/WALTER PAUK
OVERVIEW
KEY IDEAS
READ
RECALL/RECITE
REFLECT
REVIEW
LANJUTAN..
THOMAS F STATON
OHIO UNIVERSITY
PQRST
PREVIEW
QUESTION
READ
STATE
TEST
SQ3R
SURVEY
QUESTION
READ
RECITE
REVIEW
Sering
Menghafal
Tanpa
Mengerti
Lebih sulit
Buang waktu banyak
Pelajaran tetap tidak
dikuasai
Menghafal
dengan
Mengerti
Exercise
Other Mechanisms of Drug Antagonism
Not all of the mechanisms of antagonism involve interactions of drugs or endogenous ligands at
single type of receptor. Indeed, chemical antagonists need not involve a receptor at all. Thus, one drug
may antagonize the actions of a second drug by binding to and inactivating the second drug.
For example, protamine, a protein that is positively charged at physiologic pH, can be used
clinically to counteract the effects of heparin, an anticoagulant that is negatively charged; in this
case, one drug antagonizes the other simply by binding it and making it unavailable for interactions
with proteins involved in formation of a blood clot.
The clinician often uses drugs that take advantage of physiologic antagonism between endogenous
regulatory pathways. For example, several catabolic actions of the glucocorticoid hormones lead
to increased blood sugar, an effect that is physiologically opposed by insulin. Although
glucocorticoids and insulin act on quite distinct receptor-effector systems, the clinician must
sometimes administer insulin to oppose the hyperglycemic effects of glucocorticoid
hormone,whether the latter is elevated by endogenous synthesis (eg, a tumor of the adrenal
cortex) or as aresult of glucocorticoid therapy.
Cont
In general, use of a drug as a physiologic antagonist produces effects
that are less specific and less easy to control than are the effects of a
receptor-specific antagonist. Thus, for example, to treat bradycardia
caused by increased release of acetylcholine from vagus nerve
endings, the physician could use isoproterenol, a -adrenoceptor
agonist that increases heart rate by mimicking sympathetic
stimulation of the heart. However, use of this physiologic antagonist
would be less rationaland potentially more dangerousthan
would use of a receptor-specific antagonist such as atropine (a
competitive antagonist at the receptors at which acetylcholine slows
heart rate).
Cont
Until now we have considered receptor interactions and drug effects in terms of equations and
concentration-effect curves. We must also understand the molecular mechanisms by which a drugacts. Such
understanding allows us to ask basic questions with important clinical implications:
Why do some drugs produce effects that persist for minutes, hours, or even days after the
drug is no longer present?
Why do responses to other drugs diminish rapidly with prolonged or repeated
administration?
How do cellular mechanisms for amplifying external chemical signals explain the
phenomenon of spare receptors?
Why do chemically similar drugs often exhibit extraordinary selectivity in their actions?
Do these mechanisms provide targets for developing new drugs?